afferon Pages on BioPortfolio:

BioPortfolio - afferon corp
afferon corp - BioPortfolio. ... BioPortfolio - Afferon Corporation - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/afferon_corp.html...

BioPortfolio Biotechnology BioNews : live article
... Aeolus - Affectis Pharmaceuticals - Afferent - Afferon - AGY Therapeutics - Alamo Pharmaceuticals - Alexza - AlgoRx Pharmaceuticals - Algos Therapeutics ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio - Biocorporate Search
Afferon is a privately held pharmaceutical company building a specialty ... Afferon has completed the necessary pre-clinical work on its lead candidate,.
...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...

BioPortfolio - endotoxin removal with diatomaceous earth
BioPortfolio - removal of thymus biotechnology | Xenome Ltd | Moncoa Medical Research Inc | afferon | endotoxin removal with diatomaceous earth | upstate .
...
http://www.bioportfolio.com/search/endotoxin_removal_with_di...

BioPortfolio - novopharm usa inc
novopharm usa inc - BioPortfolio. ... BioPortfolio - novopharm usa inc t | gallbladder surgeons at La jolla Scripps | afferon corp | novopharm usa | sigma
...
http://www.bioportfolio.com/search/novopharm_usa_inc.html...

Results from other life science and pharmaceutical sites:

Afferon Corporation Enters Exclusive European Development and ...
WAYNE, Penn., May 3 /PRNewswire/ -- Afferon Corporation today announced that it has signed an exclusive European License, Product Development and Supply ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

New paths to pain relief - Nature Biotechnology
Afferon (Wayne, PA) has now licensed out resiniferatoxin and is testing it in phase ... Afferon has also tested resiniferatoxin topically in a phase I/IIa ...
http://www.nature.com/nbt/journal/v18/n4/full/nbt0400_387.ht...

SponsorList_Jun08
51, 3066, Afferon Corporation, 1. 52, 3694, Affinergy, Inc. 1. 53, 3158, AGA Medical Corporation, 1. 54, 3161, Agilent Technologies, 1 ...
http://www.rochester.edu/ORPA/URCOEUS/sponsoralpha.xls...

Bladder Dysfunction Associated With Multiple Sclerosis
The prospect, therefore, of using intravesical resiniferatoxin (RTX®, Afferon Corporation, Scottsdale, AZ), an ultra-potent capsaicinoid[56] that is thought
...
http://www.medscape.com/viewarticle/515091_3...

Nature Clinical Practice Urology | Therapy Insight: bladder ...
The prospect, therefore, of using intravesical resiniferatoxin (RTX®, Afferon Corporation, Scottsdale, AZ), an ultra-potent capsaicinoid56 that is thought ...
http://www.nature.com/ncpuro/journal/v2/n10/full/ncpuro0323....

Future Trends in the Treatment of Urinary Incontinence
RTX, sponsored by the Afferon Corp. (Wayne, PA), is not clinically available and has completed only preliminary phase II, FDA trials in the United States. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...

Annual Report
Afferon Corporation $82980 1. Agouron Pharmaceuticals $64000 1. Air Products and Chemicals $60420 1. Akzo Nobel $10302 1. Allergan $75450 1 ...
http://www.pitt.edu/~offres/highlights/AnnualReports/FY98.pd...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.